Post Marketing Information DHCPL 05/03/2018 Risk of gadolinium brain deposits associated with use of gadolinium-based contrast agents
INTRAVENOUS Select a brand starting with the letter: C D CLARISCAN SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 MMOL/ML [SIN15694P] CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML [SIN15693P] DOTAGRAF SOLUTION FOR INJECTION 0.5 MMOL/ML [SIN15973P] DOTAREM INJECTION 27.932 G/ 100 ML [SIN09008P]